London, United Kingdom – King Charles III of Britain has begun treatment after being diagnosed with cancer, Buckingham Palace announced Monday. The 75-year-old monarch will temporarily suspend public engagements but will continue with state business, maintaining his role as head of state.
The type of cancer was not disclosed by the palace, but it was confirmed to be unrelated to a recent treatment for a benign prostate condition. The diagnosis was made during the king’s treatment for an enlarged prostate last month, during which he spent three nights in a London hospital.
According to the palace statement, King Charles has begun a schedule of regular treatments and has been advised by doctors to postpone public-facing duties. Despite this, he remains committed to fulfilling state business and official paperwork. The monarch is being treated as an outpatient while maintaining a positive outlook on his treatment.
The decision to share his diagnosis was made in an effort to prevent speculation and to aid in public understanding of the impact of cancer on individuals around the world. This revelation comes less than two years into King Charles’s reign, following the passing of his mother, Queen Elizabeth II, at the age of 96.
The news of King Charles’s diagnosis coincides with his daughter-in-law Kate, Princess of Wales, recovering from abdominal surgery. With both temporarily sidelined, the royal ‘Firm’ faces potential strain.
U.K. political leaders and U.S. President Joe Biden have sent messages of support to the king, expressing wishes for his full and speedy recovery. The king’s decision to openly share his health battle is a departure from centuries of royal tradition of secrecy regarding health matters, demonstrating a powerful reminder of the prevalence of cancer worldwide.
Millions have shared their “collective concern” for the king’s health. Pat Price, founder of the Catch Up With Cancer campaign, emphasized the significance of the king’s openness in battling cancer, as it resonates with the many individuals who may face the disease at some point in their lives.